Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:

Why drug-resistant TB matters to the world

Today's Top Reads Close

Beyond its devastating impact on human lives, DR-TB takes a tremendous economic toll. The EIU analysis shows that, based on current incidence and prevalence rates, DR-TB deaths in a single year are estimated to cost the global economy at least US $17.8 billion.

Learn more about the report here.

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.